Related Experiment Video
Updated: Apr 9, 2026
10:51
Microfluidic Fabrication of Core-Shell Microcapsules carrying Human Pluripotent Stem Cell Spheroids
Published on: October 13, 2021
3.9K
Controlled Delivery of Human Cells by Temperature Responsive Microcapsules.
W C Mak1,2, K Olesen3, P Sivlér4
1Integrative Regenerative Medicine Centre, Department of Clinical and Experimental Medicine, Linköping University, SE58185, Linköping, Sweden. mamak@ifm.liu.se.
Journal of Functional Biomaterials
|June 23, 2015
Summary
Researchers developed temperature-responsive microcapsules for cell therapy, improving cell survival and enabling controlled release. This innovation addresses challenges in regenerative medicine by protecting therapeutic cells in adverse environments.
Area of Science:
- Regenerative Medicine
- Biomaterials Science
- Cell Biology
Background:
- Cell therapy holds promise for regenerative medicine but faces challenges like cell loss due to anoikis and harsh tissue environments.
- Encapsulation strategies are being explored to enhance therapeutic cell viability and efficacy post-transplantation.
Purpose of the Study:
- To develop a facile, high-throughput method for creating temperature-responsive microcapsules for cell delivery and controlled release.
- To investigate the use of composite microcapsules made from agarose, gelatin, and fibrinogen for enhanced cell viability and release.
Main Methods:
- Fabrication of temperature-responsive microcapsules using a combination of agarose, gelatin, and fibrinogen.
- Encapsulation and controlled release studies using human fibroblasts and human umbilical vein endothelial cells (HUVECs).
- Verification of capsule destabilization and cell release triggered by phase transition temperatures.
Main Results:
- Successful development of a high-throughput method for creating composite, temperature-responsive microcapsules.
- Demonstrated efficient encapsulation and controlled release of both human fibroblasts and HUVECs.
- Confirmed that differing phase transition temperatures of agarose and gelatin facilitate capsule destabilization for cell release.
Conclusions:
- Composite, temperature-responsive microcapsules offer a promising approach for protecting and controlling the release of therapeutic cells.
- The developed microcapsule system demonstrates potential for improving cell therapy outcomes in regenerative medicine.
- Further optimization of microcapsule composition and cell loading is required for clinical translation.
